Strategies & Technologies Driving Drug Discovery to Market
Subscribe to Drug Discovery & Development All
View Sample

FREE Email Newsletter

DDD Update

Daily news and top headlines for drug research professionals

Common Mental Health Drug Could Be Used to Treat Arthritis

July 17, 2015 8:14 am | by Queen Mary University of London | News | Comments

Lithium chloride which is used as a mood stabilizer in the treatment of mental health problems, mainly bipolar disorder, could be used to treat arthritis according to a new study. Read more...


Union Petitions to End Pharma Funding for CME

July 16, 2015 5:32 pm | by Stephanie Guzowski, Editor | News | Comments

The pharmaceutical industry’s funding of Continuing Medical Education (CME) events has drawn its share of controversy, with some saying that the practice could unfairly influence what a doctor prescribes. Unite Here, a labor union, delivered thousands of petitions to the Accrediting Council for Continuing Medical Education (ACCME) board meeting yesterday in Chicago. Read more..


National Psoriasis Foundation, Pfizer Launch Partnership for Grants

July 16, 2015 1:43 pm | News | Comments

To increase the number of people with psoriatic disease who are effectively treating their condition and improve their quality of life, the National Psoriasis Foundation and pharmaceutical company Pfizer will award up to $1 million in learning and change grants through a new grant program. Read more...


Making 'Miniature Brains' from Skin Cells to Better Understand Autism

July 16, 2015 1:34 pm | by Yale University | News | Comments

A larger head size—or macrocephaly—is seen in many children with severe autism spectrum disorder (ASD). A new stem cell study of these children by Yale School of Medicine researchers could help predict ASD and may lead to new drug targets for autism treatment. Read more...


GSK Begins Shipping 2015-16 U.S. Flu Vaccines

July 16, 2015 1:23 pm | News | Comments

GSK announced today it has begun shipping Fluarix Quadrivalent (Influenza Vaccine) doses to US healthcare providers, following licensing and lot-release approval from the US Food and Drug Administration’s (FDA) Center for Biologics Evaluation and Research. Read more...


Child Paralysis Outbreak: UVA Identifies Potential Cause

July 16, 2015 1:15 pm | by University of Virginia | News | Comments

A mysterious outbreak of child paralysis cases previously linked to enterovirus D68 may instead have another cause, doctors at the University of Virginia Children’s Hospital are cautioning after determining that a stricken child appeared to be suffering from a different virus. Read more...


UnitedHealth Tops Street 2Q Forecasts, Raises Forecasts

July 16, 2015 12:43 pm | by Tom Murphy, AP Business Writer | News | Comments

UnitedHealth continued to juice up its business outside health insurance in a better-than-expected second quarter while rivals scrambled to add enrollment in a wave of mega-mergers sweeping the sector. Read more...


Device Offers Remote-Controlled Drug Delivery

July 16, 2015 12:27 pm | by Stephanie Guzowski, Editor | News | Comments

A wireless device, demonstrated for the first time in mice, can be implanted in the brain and activated by the remote push of a button to deliver drugs, according to a study published today in the journal Cell. Read more...


Study: Differences in Brain Wiring Responsible for Different Trauma Recoveries

July 16, 2015 8:58 am | by Seth Augenstein, Digital Reporter | News | Comments

Some young people quickly recover from traumatic brain injuries, while others take much longer to recover – if they ever do at all. The difference appears to be in the brain’s wiring system – and not the overall severity of the injury, according to a new study published in the Journal of Neuroscience Wednesday. Read more...


Transplant Drug Could Turn the Tide of Heart Attack Damage

July 15, 2015 4:41 pm | News | Comments

New research has revealed how a drug commonly used after transplant operations could limit some of the heart damage caused by a heart attack, in a study from Newcastle University. Read more...


Oxford Ebola Vaccine Study Moves to Next Phase

July 15, 2015 4:36 pm | by Oxford University | News | Comments

The EBOVAC2 project is funded under a grant from the European Commission’s Innovative Medicine Initiative Ebola+ programme which was launched in response to the Ebola virus disease outbreak. The EBOVAC2 project aims to assess the safety and immunogenicity of a novel prime boost preventative vaccine regimen against Ebola Virus Disease (EVD). Read more...


Chemists Help Develop a Novel Drug to Fight Malaria

July 15, 2015 4:32 pm | by University of Washington | News | Comments

An international team of scientists — led by researchers from the University of Washington and two other institutions — has announced that a new compound to fight malaria is ready for human trials. Read more...


Pfizer to Close India Manufacturing Plant

July 15, 2015 2:36 pm | by Stephanie Guzowski, Editor | News | Comments

Pfizer will close its 50-year-old Thane manufacturing facility in Mumbai, by September 16, 2015, the company announced Wednesday. The facility has had no production activity since 2013, and the closure will not impact the supply of any of its medicines, according to Pfizer. Read more...


Taiwan's Pharmaceutical Market Value will Hit $8.4B by 2020

July 15, 2015 2:32 pm | by Joshua Owide, Director of Healthcare Industry Dynamics, GlobalData | Articles | Comments

This growth will happen despite diplomatic tensions.


Wider Use of Statins Has Positive Results, Say New Studies

July 15, 2015 1:16 pm | by Ryan Bushey, Associate Editor | Articles | Comments

The Journal of the American Medical Association (JAMA) published two new studies on Tuesday that support controversial cholesterol guidelines. Read more...



You may login with either your assigned username or your e-mail address.
The password field is case sensitive.